Search All News
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
Source:The New York TimesAugust 12, 2014
- July 15, 2014
NewYork-Presbyterian Hospital is No. 6 in the country and No. 1 in New York in this year's U.S. News & World Report's hospital ranking.
- July 7, 2014
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
- June 9, 2014
A new study measures the risk of developing Parkinson's for people with Gaucher disease and Gaucher carriers.
- May 28, 2014
Columbia researchers have taken a significant step forward toward deciphering the genetics of schizophrenia, which could have important implications for early detection of the condition.
- May 21, 2014
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
- May 15, 2014
Those with both migraine and vascular risk factors may want to pay even greater attention to lifestyle changes that can reduce stroke risk.
- May 15, 2014
NYP/CUMC promotes awareness of and offers expertise in a rare genetic disorder that causes tuberous growths in vital organs.
- May 13, 2014
Racial disparities in stroke are due primarily to higher rates and poorer treatment of hypertension, diabetes, and high cholesterol among black Americans.